Yukako Kayashima1, Natalia Makhanova1, Nobuyo Maeda2. 1. From the Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill. 2. From the Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill. nobuyo@med.unc.edu.
Abstract
OBJECTIVE: Arch atherosclerosis 4 (Aath4) is a quantitative trait locus for atherosclerotic plaque formation in the inner curve of the aortic arch previously identified in an F2 cross of Apoe-/- mice on DBA/2J and 129S6 backgrounds. C-mer proto-oncogene tyrosine kinase (Mertk), coding for a ligand-activated transmembrane tyrosine kinase, is a candidate gene within the same chromosomal region. Our objective was to determine whether strain differences in Mertk influence plaque formation. APPROACH AND RESULTS: To dissect the strain effects of Mertk on atherosclerosis, we first established a congenic mouse line (Aath4aDBA/DBA ) in which a 5' region of Aath4 of DBA/2J, including Mertk, was backcrossed onto a 129S6-Apoe-/- background. The resulting Aath4aDBA/DBA male mice developed significantly larger plaques compared with control mice (Aath4a129/129 ), proving that the DBA/2J allele of Aath4a is proatherogenic. Thioglycollate-elicited peritoneal macrophages from Aath4aDBA/DBA mice express less than 50% of Mertk mRNA and cell-surface MERTK protein compared with those from the control mice. Moreover, both large and small peritoneal Aath4aDBA/DBA macrophages showed reduced phagocytosis of apoptotic cells. When Mertk cDNAs from 129S6 and DBA/2J mice were overexpressed in HEK293T (human embryonic kidney 293T) cells, phagocytosis of apoptotic cells was equally enhanced in direct proportion to Mertk levels, indicating that phagocytosis is modulated by the amount of MERTK, but that it is not affected by MERTK amino acid differences between 129S6 and DBA/2J. CONCLUSIONS: Reduced transcription of Mertk, rather than differences in MERTK protein structure, determines the reduced efficiency of apoptotic cell clearance in the Aath4aDBA/DBA mice, which, in turn, contributes to their increased susceptibility to atherosclerosis.
OBJECTIVE: Arch atherosclerosis 4 (Aath4) is a quantitative trait locus for atherosclerotic plaque formation in the inner curve of the aortic arch previously identified in an F2 cross of Apoe-/- mice on DBA/2J and 129S6 backgrounds. C-mer proto-oncogene tyrosine kinase (Mertk), coding for a ligand-activated transmembrane tyrosine kinase, is a candidate gene within the same chromosomal region. Our objective was to determine whether strain differences in Mertk influence plaque formation. APPROACH AND RESULTS: To dissect the strain effects of Mertk on atherosclerosis, we first established a congenic mouse line (Aath4aDBA/DBA ) in which a 5' region of Aath4 of DBA/2J, including Mertk, was backcrossed onto a 129S6-Apoe-/- background. The resulting Aath4aDBA/DBA male mice developed significantly larger plaques compared with control mice (Aath4a129/129 ), proving that the DBA/2J allele of Aath4a is proatherogenic. Thioglycollate-elicited peritoneal macrophages from Aath4aDBA/DBAmice express less than 50% of Mertk mRNA and cell-surface MERTK protein compared with those from the control mice. Moreover, both large and small peritoneal Aath4aDBA/DBA macrophages showed reduced phagocytosis of apoptotic cells. When Mertk cDNAs from 129S6 and DBA/2J mice were overexpressed in HEK293T (humanembryonic kidney 293T) cells, phagocytosis of apoptotic cells was equally enhanced in direct proportion to Mertk levels, indicating that phagocytosis is modulated by the amount of MERTK, but that it is not affected by MERTK amino acid differences between 129S6 and DBA/2J. CONCLUSIONS: Reduced transcription of Mertk, rather than differences in MERTK protein structure, determines the reduced efficiency of apoptotic cell clearance in the Aath4aDBA/DBAmice, which, in turn, contributes to their increased susceptibility to atherosclerosis.
Authors: Jacque L Duncan; Matthew M LaVail; Douglas Yasumura; Michael T Matthes; Haidong Yang; Nikolaus Trautmann; Aimee V Chappelow; Wei Feng; H Shelton Earp; Glenn K Matsushima; Douglas Vollrath Journal: Invest Ophthalmol Vis Sci Date: 2003-02 Impact factor: 4.799
Authors: R S Scott; E J McMahon; S M Pop; E A Reap; R Caricchio; P L Cohen; H S Earp; G K Matsushima Journal: Nature Date: 2001-05-10 Impact factor: 49.962
Authors: Brian J Bennett; Charles R Farber; Luz Orozco; Hyun Min Kang; Anatole Ghazalpour; Nathan Siemers; Michael Neubauer; Isaac Neuhaus; Roumyana Yordanova; Bo Guan; Amy Truong; Wen-pin Yang; Aiqing He; Paul Kayne; Peter Gargalovic; Todd Kirchgessner; Calvin Pan; Lawrence W Castellani; Emrah Kostem; Nicholas Furlotte; Thomas A Drake; Eleazar Eskin; Aldons J Lusis Journal: Genome Res Date: 2010-01-06 Impact factor: 9.043
Authors: Qimin Hai; Brian Ritchey; Peggy Robinet; Alexander M Alzayed; Greg Brubaker; Jinying Zhang; Jonathan D Smith Journal: Arterioscler Thromb Vasc Biol Date: 2017-11-02 Impact factor: 8.311
Authors: Richard Witas; Astrid Rasmussen; Robert H Scofield; Lida Radfar; Donald U Stone; Kiely Grundahl; David Lewis; Kathy L Sivils; Christopher J Lessard; A Darise Farris; Cuong Q Nguyen Journal: Int J Mol Sci Date: 2021-09-08 Impact factor: 6.208
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Yukako Kayashima; Connor A Clanton; Amanda M Lewis; Xinghui Sun; Sylvia Hiller; Phillip Huynh; Jennifer Wilder; John Hagaman; Feng Li; Nobuyo Maeda-Smithies; Edward N Harris Journal: Front Cardiovasc Med Date: 2022-03-11
Authors: Carlos Guijas; Lucy E Horton; Linh Hoang; Xavier Domingo-Almenara; Elizabeth M Billings; Brian C Ware; Brian Sullivan; Gary Siuzdak Journal: Metabolites Date: 2022-07-14